Cash flow Kokusai Co., Ltd.

Equities

7722

JP3293700005

Industrial Machinery & Equipment

Market Closed - Japan Exchange Other stock markets 02:30:00 2025-06-13 EDT			5-day change	1st Jan Change
578.00 ^JPY	+0.70%		+0.17%	+16.06%

05-15	Tranche Update on Kokusai Co., Ltd.'s Equity Buyback Plan announced on May 15, 2025.	CI
05-15	Kokusai Co., Ltd.'s Equity Buyback announced on May 15, 2025 has closed with of 63,200 shares, representing 0.47% for ¥35.08 million.	CI

2aa27e2245c848.bame0msne6VTv39pXIPOCsfabdaowODURaYPOTNIA4o.NerPnD1sFd0hzC4MZM2iZqKTW-_k99S5Nu1KdGN5Vvk0mMyoWR8D6mv9Rw

Published financial data: KOKUSAI CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	12.89B	11.5B	11.13B	10.04B	10.24B
Total Revenues	12.89B	11.5B	11.13B	10.04B	10.24B
Cost of Goods Sold, Total	7.57B	7.89B	7.57B	7.12B	7.54B
Gross Profit	5.32B	3.62B	3.56B	2.92B	2.69B
Selling General & Admin Expenses, Total	3.06B	3.01B	2.84B	2.72B	3B
Provision for Bad Debts	-25M	28M	94M	44M	134M
R&D Expenses	20M	38M	45M	116M	63M
Depreciation & Amortization - (IS)	33M	33M	30M	40M	37M
Other Operating Expenses	170M	97M	107M	36M	76M
Other Operating Expenses, Total	3.26B	3.2B	3.11B	2.96B	3.31B
Operating Income	2.07B	412M	446M	-39M	-612M
Interest Expense, Total	-11M	-10M	-13M	-21M	-26M
Interest And Investment Income	49M	42M	32M	95M	160M
Net Interest Expenses	38M	32M	19M	74M	134M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-2M	48M	181M	138M	313M
Other Non Operating Income (Expenses)	-59M	58M	70M	15M	10M
EBT, Excl. Unusual Items	2.04B	550M	716M	188M	-155M
Gain (Loss) On Sale Of Investments	-	16M	-	-	-
Asset Writedown	-	-	-	-	-1M
EBT, Incl. Unusual Items	2.04B	566M	716M	188M	-156M
Income Tax Expense	503M	376M	221M	219M	69M
Earnings From Continuing Operations	1.54B	190M	495M	-31M	-225M
Net Income to Company	1.54B	190M	495M	-31M	-225M
Minority Interest	-15M	-11M	-20M	-35M	-33M
Net Income - (IS)	1.52B	179M	475M	-66M	-258M
Net Income to Common Incl Extra Items	1.52B	179M	475M	-66M	-258M
Net Income to Common Excl. Extra Items	1.52B	179M	475M	-66M	-258M
Per Share Items
Net EPS - Basic	108.81	12.73	34.24	-4.8	-18.77
Basic EPS - Continuing Operations	108.81	12.73	34.24	-4.8	-18.77
Basic Weighted Average Shares Outstanding	14.02M	14.06M	13.87M	13.75M	13.75M
Net EPS - Diluted	108.81	12.73	34.24	-4.8	-18.77
Diluted EPS - Continuing Operations	108.81	12.73	34.24	-4.8	-18.77
Diluted Weighted Average Shares Outstanding	14.02M	14.06M	13.87M	13.75M	13.75M
Normalized Basic EPS	90.04	23.67	30.82	6	-9.45
Normalized Diluted EPS	90.04	23.67	30.82	6	-9.45
Dividend Per Share	30	25	20	20	20
Payout Ratio	27.61	274.3	58.53	-416.67	-106.2
Supplemental Items
EBITDA	2.19B	552M	585M	126M	-461M
EBITA	2.07B	412M	446M	-39M	-612M
EBIT	2.07B	412M	446M	-39M	-612M
Effective Tax Rate - (Ratio)	24.62	66.43	30.87	116.49	-44.23
Normalized Net Income	1.26B	333M	428M	82.5M	-130M
Non-Cash Pension Expense	63.4M	76.4M	64.45M	67.33M	71.55M
Supplemental Operating Expense Items
Selling and Marketing Expenses	370M	324M	362M	267M	264M
General and Administrative Expenses	408M	400M	392M	335M	310M
Research And Development Expense From Footnotes	20M	38M	45M	116M	63M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.24B	5.91B	5.45B	7.41B	8.25B
Total Cash And Short Term Investments	5.24B	5.91B	5.45B	7.41B	8.25B
Accounts Receivable, Total	3.45B	2.68B	3.2B	3.81B	3.63B
Other Receivables	8M	33M	34M	52M	56M
Total Receivables	3.46B	2.71B	3.24B	3.86B	3.69B
Inventory	4.28B	4.33B	3.14B	3.78B	3.5B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	273M	455M	314M	383M	356M
Total Current Assets	13.25B	13.41B	12.14B	15.44B	15.79B
Net Property Plant And Equipment	2.91B	3.1B	3B	2.95B	2.87B
Long-term Investments	1.99B	2.09B	2.1B	1.96B	1.78B
Other Intangibles, Total	75M	68M	61M	52M	55M
Loans Receivable Long-Term	10M	8M	-	-	-
Deferred Tax Assets Long-Term	10M	18M	63M	11M	19M
Other Long-Term Assets, Total	1M	1M	1M	1M	2M
Total Assets	18.24B	18.69B	17.37B	20.41B	20.52B
Liabilities
Accounts Payable, Total	2.3B	2.4B	1.32B	1.9B	1.96B
Accrued Expenses, Total	116M	88M	87M	115M	89M
Short-term Borrowings	840M	1.32B	1.43B	1.6B	1.34B
Current Portion of Long-Term Debt	225M	370M	474M	520M	555M
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	446M	140M	218M	83M	72M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	2.44B	1.92B	1.47B	1.76B	2.89B
Total Current Liabilities	6.37B	6.24B	5B	5.98B	6.91B
Long-Term Debt	233M	789M	570M	2.67B	2.12B
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	370M	369M	380M	383M	376M
Deferred Tax Liability Non Current	102M	144M	103M	94M	73M
Other Non Current Liabilities	15M	22M	21M	39M	22M
Total Liabilities	7.09B	7.57B	6.07B	9.16B	9.5B
Common Stock, Total	1.02B	1.02B	1.02B	1.02B	1.02B
Additional Paid In Capital	936M	936M	936M	936M	936M
Retained Earnings	9.16B	8.84B	9.04B	8.7B	8.16B
Treasury Stock	-151M	-99M	-327M	-327M	-327M
Comprehensive Income and Other	44M	275M	460M	697M	943M
Total Common Equity	11.01B	10.97B	11.13B	11.02B	10.74B
Minority Interest	145M	149M	169M	225M	277M
Total Equity	11.15B	11.12B	11.3B	11.25B	11.01B
Total Liabilities And Equity	18.24B	18.69B	17.37B	20.41B	20.52B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14.02M	14.08M	13.75M	13.75M	13.75M
ECS Total Common Shares Outstanding	14.02M	14.08M	13.75M	13.75M	13.75M
Book Value / Share	785.49	779.49	809.41	801.84	780.97
Tangible Book Value	10.93B	10.91B	11.07B	10.97B	10.68B
Tangible Book Value Per Share	780.14	774.66	804.97	798.06	776.97
Total Debt	1.3B	2.48B	2.48B	4.79B	4.01B
Net Debt	-3.95B	-3.44B	-2.98B	-2.62B	-4.23B
Debt Equivalent of Unfunded Proj. Benefit Obligation	220M	192M	193M	208M	192M
Minority Interest, Total (Incl. Fin. Div)	145M	149M	169M	225M	277M
Inventories - Raw Materials, Total	665M	546M	657M	699M	774M
Inventories - Work In Process, Total	3B	3.15B	1.84B	2.7B	2.41B
Inventories - Finished Goods, Total	606M	638M	636M	386M	318M
Inventories - Others	1M	-	1M	-	1M
Full Time Employees	314	299	288	286	287
Accumulated Allowance for Doubtful Accounts (Supple)	5M	3M	3M	7M	13M
Order Backlog	11.16B	9.78B	7.51B	8.23B	12.36B

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	2.04B	567M	717M	188M	-155M
Depreciation & Amortization - CF	126M	140M	139M	165M	151M
Depreciation & Amortization, Total	126M	140M	139M	165M	151M
(Gain) Loss From Sale Of Asset	-	-	-	-	1M
(Gain) Loss on Sale of Investments - (CF)	-	-16M	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-170M	-620M	-141M	-351M	-85M
Change In Accounts Receivable	551M	782M	-480M	-552M	238M
Change In Inventories	-865M	1M	1.23B	-622M	363M
Change In Accounts Payable	-69M	99M	-1.09B	568M	41M
Change in Other Net Operating Assets	909M	-930M	-487M	133M	782M
Cash from Operations	2.53B	23M	-119M	-471M	1.34B
Capital Expenditure	-409M	-285M	-9M	-42M	-48M
Divestitures	-	16M	-	-	-
Sale (Purchase) of Intangible assets	-3M	-2M	-1M	-	-4M
Investment in Marketable and Equity Securities, Total	-334M	-197M	251M	38M	-467M
Net (Increase) Decrease in Loans Originated / Sold - Investing	0	2M	-	-	-
Other Investing Activities, Total	263M	-35M	-16M	133M	1M
Cash from Investing	-483M	-501M	225M	129M	-518M
Short Term Debt Issued, Total	-	480M	112M	168M	-
Long-Term Debt Issued, Total	-	1B	350M	2.7B	-
Total Debt Issued	-	1.48B	462M	2.87B	-
Short Term Debt Repaid, Total	-300M	-	-	-	-260M
Long-Term Debt Repaid, Total	-228M	-299M	-465M	-558M	-512M
Total Debt Repaid	-528M	-299M	-465M	-558M	-772M
Repurchase of Common Stock	-	-	-227M	-	-
Common & Preferred Stock Dividends Paid	-421M	-491M	-278M	-275M	-274M
Common & Preferred Stock Dividends Paid	-421M	-491M	-278M	-275M	-274M
Other Financing Activities, Total	-	-	-1M	-1M	-
Cash from Financing	-949M	690M	-509M	2.03B	-1.05B
Foreign Exchange Rate Adjustments	-56M	12M	164M	164M	276M
Miscellaneous Cash Flow Adjustments	-	-1M	1M	-	-2M
Net Change in Cash	1.04B	223M	-238M	1.86B	46M
Supplemental Items
Cash Interest Paid	9M	9M	12M	22M	24M
Cash Income Tax Paid (Refund)	171M	685M	203M	329M	73M
Levered Free Cash Flow	1.8B	-132M	-254M	-486M	1.34B
Unlevered Free Cash Flow	1.81B	-126M	-246M	-473M	1.36B
Change In Net Working Capital	-805M	236M	654M	572M	-1.64B
Net Debt Issued / Repaid	-528M	1.18B	-3M	2.31B	-772M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.34	1.39	1.55	-0.13	-1.87
Return on Total Capital	10.53	1.98	2.04	-0.16	-2.46
Return On Equity %	14.39	1.71	4.42	-0.27	-2.02
Return on Common Equity	14.43	1.63	4.3	-0.6	-2.37
Margin Analysis
Gross Profit Margin %	41.3	31.43	31.99	29.1	26.31
SG&A Margin	23.74	26.15	25.51	27.14	29.26
EBITDA Margin %	17	4.8	5.26	1.26	-4.5
EBITA Margin %	16.02	3.58	4.01	-0.39	-5.98
EBIT Margin %	16.02	3.58	4.01	-0.39	-5.98
Income From Continuing Operations Margin %	11.94	1.65	4.45	-0.31	-2.2
Net Income Margin %	11.83	1.56	4.27	-0.66	-2.52
Net Avail. For Common Margin %	11.83	1.56	4.27	-0.66	-2.52
Normalized Net Income Margin	9.79	2.89	3.84	0.82	-1.27
Levered Free Cash Flow Margin	13.99	-1.15	-2.29	-4.85	13.09
Unlevered Free Cash Flow Margin	14.04	-1.09	-2.21	-4.72	13.25
Asset Turnover
Asset Turnover	0.73	0.62	0.62	0.53	0.5
Fixed Assets Turnover	4.65	3.83	3.65	3.37	3.52
Receivables Turnover (Average Receivables)	3.44	3.75	3.78	2.86	2.75
Inventory Turnover (Average Inventory)	1.95	1.83	2.03	2.06	2.07
Short Term Liquidity
Current Ratio	2.08	2.15	2.43	2.58	2.28
Quick Ratio	1.37	1.38	1.74	1.88	1.73
Operating Cash Flow to Current Liabilities	0.4	0	-0.02	-0.08	0.19
Days Sales Outstanding (Average Receivables)	106.25	97.21	96.44	127.61	133.05
Days Outstanding Inventory (Average Inventory)	187.5	199.09	180.04	177.34	176.6
Average Days Payable Outstanding	101.74	108.08	106.74	75.81	97.34
Cash Conversion Cycle (Average Days)	192.01	188.21	169.74	229.14	212.3
Long Term Solvency
Total Debt/Equity	11.64	22.29	21.92	42.55	36.44
Total Debt / Total Capital	10.42	18.23	17.98	29.85	26.71
LT Debt/Equity	2.09	7.09	5.05	23.7	19.24
Long-Term Debt / Total Capital	1.87	5.8	4.14	16.63	14.1
Total Liabilities / Total Assets	38.87	40.49	34.97	44.89	46.32
EBIT / Interest Expense	187.82	41.2	34.31	-1.86	-23.54
EBITDA / Interest Expense	199.27	55.2	45	6	-17.73
(EBITDA - Capex) / Interest Expense	162.09	26.7	44.31	4	-19.58
Total Debt / EBITDA	0.59	4.49	4.23	37.98	-8.71
Net Debt / EBITDA	-1.8	-6.22	-5.09	-20.83	9.18
Total Debt / (EBITDA - Capex)	0.73	9.28	4.3	56.98	-7.89
Net Debt / (EBITDA - Capex)	-2.21	-12.87	-5.17	-31.24	8.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	22.26	-10.77	-3.29	-9.8	2.01
Gross Profit, 1 Yr. Growth %	38.46	-32.09	-1.55	-17.95	-7.77
EBITDA, 1 Yr. Growth %	189.56	-74.82	5.98	-78.46	-465.87
EBITA, 1 Yr. Growth %	223.82	-80.06	8.25	-108.74	1.47K
EBIT, 1 Yr. Growth %	223.82	-80.06	8.25	-108.74	1.47K
Earnings From Cont. Operations, 1 Yr. Growth %	320.76	-87.66	160.53	-106.26	625.81
Net Income, 1 Yr. Growth %	345.91	-88.26	165.36	-113.89	290.91
Normalized Net Income, 1 Yr. Growth %	193.2	-73.63	28.47	-80.7	-257.42
Diluted EPS Before Extra, 1 Yr. Growth %	345.91	-88.3	168.88	-114.02	290.91
Accounts Receivable, 1 Yr. Growth %	-14.38	-22.53	19.81	18.97	-4.77
Inventory, 1 Yr. Growth %	22.91	1.26	-27.6	20.57	-7.38
Net Property, Plant and Equip., 1 Yr. Growth %	10.23	6.6	-3.26	-1.67	-2.78
Total Assets, 1 Yr. Growth %	7.75	2.44	-7.06	17.51	0.51
Tangible Book Value, 1 Yr. Growth %	8.56	-0.26	1.48	-0.86	-2.64
Common Equity, 1 Yr. Growth %	8.72	-0.32	1.4	-0.93	-2.6
Cash From Operations, 1 Yr. Growth %	368.65	-99.09	-617.39	295.8	-383.65
Capital Expenditures, 1 Yr. Growth %	549.21	-30.32	-96.84	366.67	14.29
Levered Free Cash Flow, 1 Yr. Growth %	181.56	-107.31	93.07	91.25	-375.49
Unlevered Free Cash Flow, 1 Yr. Growth %	179.9	-106.93	96.22	92.23	-386.56
Dividend Per Share, 1 Yr. Growth %	0	-16.67	-20	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.98	4.45	-7.1	-6.6	-4.07
Gross Profit, 2 Yr. CAGR %	14.92	-3.04	-18.24	-10.12	-13.01
EBITDA, 2 Yr. CAGR %	14.81	-14.61	-48.34	-52.22	-11.23
EBITA, 2 Yr. CAGR %	15.56	-19.64	-53.54	-69.23	17.14
EBIT, 2 Yr. CAGR %	15.56	-19.64	-53.54	-69.23	17.14
Earnings From Cont. Operations, 2 Yr. CAGR %	32.36	-27.95	-43.31	-59.61	-32.58
Net Income, 2 Yr. CAGR %	32.62	-27.65	-44.19	-39.28	-26.3
Normalized Net Income, 2 Yr. CAGR %	20.97	-12.07	-41.8	-50.21	-44.88
Diluted EPS Before Extra, 2 Yr. CAGR %	32.62	-27.76	-43.91	-38.6	-25.97
Accounts Receivable, 2 Yr. CAGR %	-11.19	-18.56	-3.66	19.39	6.44
Inventory, 2 Yr. CAGR %	37.19	11.56	-14.38	-6.57	5.68
Net Property, Plant and Equip., 2 Yr. CAGR %	3.86	8.4	1.55	-2.47	-2.22
Total Assets, 2 Yr. CAGR %	6.16	5.06	-2.42	4.51	8.68
Tangible Book Value, 2 Yr. CAGR %	2.75	4.06	0.61	0.3	-1.75
Common Equity, 2 Yr. CAGR %	2.84	4.1	0.54	0.23	-1.77
Cash From Operations, 2 Yr. CAGR %	98.98	-79.34	-78.3	352.53	235.07
Capital Expenditures, 2 Yr. CAGR %	232.48	112.69	-85.17	-61.61	130.94
Levered Free Cash Flow, 2 Yr. CAGR %	70.6	-54.65	-62.44	92.16	129.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	70.07	-55.95	-63.12	94.21	134.7
Dividend Per Share, 2 Yr. CAGR %	0	-8.71	-18.35	-10.56	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.16	0.07	1.8	-8.01	-3.81
Gross Profit, 3 Yr. CAGR %	11.84	-3.56	-2.54	-18.14	-9.35
EBITDA, 3 Yr. CAGR %	25.16	-30.76	-8.23	-61.41	-5.83
EBITA, 3 Yr. CAGR %	27.53	-35.66	-11.25	-73.37	14.1
EBIT, 3 Yr. CAGR %	27.53	-35.66	-11.25	-73.37	14.1
Earnings From Cont. Operations, 3 Yr. CAGR %	39.85	-39.99	10.59	-72.8	5.8
Net Income, 3 Yr. CAGR %	40.74	-40.9	11.57	-64.89	12.96
Normalized Net Income, 3 Yr. CAGR %	29.47	-27.2	-0.22	-59.72	-26.92
Diluted EPS Before Extra, 3 Yr. CAGR %	40.74	-40.96	11.95	-64.66	13.8
Accounts Receivable, 3 Yr. CAGR %	-3.41	-15.14	-7.37	3.36	10.72
Inventory, 3 Yr. CAGR %	15.13	23.98	-3.41	-4.03	-6.84
Net Property, Plant and Equip., 3 Yr. CAGR %	1.66	4.76	4.37	0.47	-2.57
Total Assets, 3 Yr. CAGR %	3.52	4.91	0.86	3.81	3.16
Tangible Book Value, 3 Yr. CAGR %	4.05	1.74	3.19	0.12	-0.69
Common Equity, 3 Yr. CAGR %	4.11	1.77	3.2	0.05	-0.73
Cash From Operations, 3 Yr. CAGR %	54.05	-66.97	-39.56	-42.87	287.28
Capital Expenditures, 3 Yr. CAGR %	133.81	97.49	-47.72	-53.17	-44.78
Levered Free Cash Flow, 3 Yr. CAGR %	42.66	-40.31	-26.49	-35.39	116.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	42.13	-41.47	-27.52	-36.05	121.1
Dividend Per Share, 3 Yr. CAGR %	0	-5.9	-12.64	-12.64	-7.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5.09	-5.07	0.07	-2.65	-0.59
Gross Profit, 5 Yr. CAGR %	-5.2	-8.47	-1.33	-6.24	-6.87
EBITDA, 5 Yr. CAGR %	-9.27	-26.2	-12.15	-40.31	-9.44
EBITA, 5 Yr. CAGR %	-9.59	-29.61	-14.84	-52.1	-0.83
EBIT, 5 Yr. CAGR %	-9.59	-29.61	-14.84	-52.1	-0.83
Earnings From Cont. Operations, 5 Yr. CAGR %	-3.81	-32.23	-2.54	-48.78	-9.27
Net Income, 5 Yr. CAGR %	-3.96	-32.89	-2.78	-40.25	-5.48
Normalized Net Income, 5 Yr. CAGR %	-10.38	-24.91	-5.97	-37.46	-21.31
Diluted EPS Before Extra, 5 Yr. CAGR %	-3.96	-32.93	-2.58	-40.02	-5.12
Accounts Receivable, 5 Yr. CAGR %	-2.89	-8.22	-3.51	-2.73	-2.08
Inventory, 5 Yr. CAGR %	1.18	6.99	2.27	10.72	0.13
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.69	1.64	1.62	1.81	1.68
Total Assets, 5 Yr. CAGR %	-1.71	1.54	1.1	4.75	3.92
Tangible Book Value, 5 Yr. CAGR %	2.44	2.11	2.66	1.16	1.18
Common Equity, 5 Yr. CAGR %	2.45	2.12	2.66	1.15	1.18
Cash From Operations, 5 Yr. CAGR %	0.74	-25.17	-29.66	-5.89	19.91
Capital Expenditures, 5 Yr. CAGR %	38.94	53.91	-22.41	2.57	-5.29
Levered Free Cash Flow, 5 Yr. CAGR %	-5.47	0.35	-16.35	-4.72	15.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-5.51	-2.44	-17.14	-5.43	15.97
Dividend Per Share, 5 Yr. CAGR %	-12.94	-17.4	-7.79	-7.79	-7.79